Significant differences were found between papillary and non-papillary BLCA tumors, and papillary tumors had a 1.854-fold higher likelihood of presenting a high expression of mex3a (P=0.006, OR=1.854). Here, MEX3A is linked to bladder transitional cell carcinoma.